Untreated iron deficiency is an important cause of hyporesponsiveness to ESA therapy, and is one of only a few other easily reversible factors that contribute to a lack of ESA treatment effect on Hb levels [10]. The gene discussed is GSTM1; the disease is nutritional disorder.